Health

NHS set to pilot GRAIL’s wide-ranging cancer blood test – PMLiVE

Previous study indicates test can detect over 50 cancer types

Published

5 years ago

December 2, 2020

The UK’s National Health Service (NHS) has signed a deal with healthcare company GRAIL to pilot its novel cancer blood test in 165,000 patients.
The Galleri blood test will be offered to 165,000 patients by NHS England in a new programme aimed at detecting early stage cancers.
The blood test identifies signs of a range of cancer types by searching for small fragments of DNA and RNA from tumours in the bloodstream to determine the presence of cancer.
The NHS will identify programme participants…

Click here to view the original article.

Related Topics:Australia PMLiVE

Up Next

Measles mumps-rubella vaccine may help protect kids against COVID-19 – Sydney Morning Herald

Don't Miss

Two Global Efforts Try to Trace the Origin of the Covid Virus – WIRED

Noosa News21 hours ago

Missing wills – October 2025 – Proctor

Noosa News12 hours ago

Power outages, traffic delays after truck smashed power pole; 100 years since Greater Brisbane was formed; Lions victory set to be plastered onto a Metro